Company Profile

Member Since

  • 2018

Membership Category

  • API/Intermediates Sales and Mfg

Contact Information

Yokohama 230-0045


  • Founded in 2005, Jitsubo is a Japanese pharmaceutical company focused on innovative peptide therapeutics with proprietary technology called Molecular Hiving. Jitsubo's new-generation peptide synthesis technology realizes the key advantages offered by the standard methods for manufacturing peptides, solid phase peptide synthesis (SPPS) and liquid phase peptide synthesis (LPPS). By using its patent-protected achiral hydrophobic tags, the solubility of peptides can be controlled between soluble and insoluble forms, depending on the solvent used. Molecular Hiving enables peptides manufacturing at high-yield and purity which leads to significant lower cost compared to LPPS and SPPS.

Number of Employees

  • 1 - 49